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Summary
Background:  The  application  of  a  new  generation  of  photosensitizers  to  increase  the  efﬁcacy
of antifungal  photodynamic  therapy  (aPDT)  is  an  important  aspect  of  PDT.  Thus,  this  in  vitro
study is  aimed  to  evaluate  the  antifungal  efﬁcacy  of  the  photo-elimination  of  Candida  albicans
with photothermal  and  antifungal  photodynamic  therapy.
Method  and  material:  aPDT  with  new  methylene  blue  and  photothermal  therapy  with  EmunDo®
were  applied  to  a  fungal  suspension,  which  was  then  subcultured  in  Sabouraud  dextrose  agar
(SDA). The  C.  albicans  colonies  were  counted  and  are  expressed  as  colony-forming  unit  per
milliliter (CFU/ml).
Results:  aPDT  with  either  EmunDo® or  new  methylene  blue  (NMB)  considerably  diminished  the
viability of  inoculated  C.  albicans  (P  <  0.001)  by  log  reduction  of  1.9  and  3.37,  respectively,
compared  with  the  control  group  respectively,  compared  with  the  control  group.  The  antifungal
potency or  dark  toxicity  of  the  two  photosensitizers  alone  did  not  signiﬁcantly  differ  (P  =  0.70).
The same  trend  was  observed  for  the  light  sources  (:  810  nm  vs.  :  630  nm),  which  also  did  not
signiﬁcantly  differ  (P  =  0.78).
Conclusion:  The  photo-elimination  of  C.  albicans  with  either  new  methylene  blue  or  EmunDo®as  a  photosensitizer  can  reduce  the  viability  of  fungal  cells.  Although  the  result  of  this  study  is
encouraging,  further  investigati
and safe  application  of  this  met
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Light  sources
The  light  source  used  to  activate  NMB  was  a  InGaAIP  red
light  laser  (MUSTANG,  Russia)  source,  and  the  samples  were
Figure  1  Chemical  structure  of  new  methylene  blue  used  in
the study.In  vitro  photodynamic  inactivation  of  Candida  albicans  
Introduction
Oral  candidiasis  is  the  most  common  opportunistic  infec-
tion  that  inﬂuences  the  oral  mucosa.  The  most  predominant
etiological  agent  in  oral  candidiasis  is  Candida  albicans,
which  corresponds  to  70—80%  of  all  microorganisms  iso-
lated  from  oral  lesions  [1,2].  Oral  candidiasis  is  a  common
manifestation  of  fungal  infections,  especially  in  immuno-
compromised  patients,  such  as  HIV/AIDS  patients  and
cancer  patients  receiving  radiotherapy  and  chemother-
apy  [3].  This  microorganism  does  not  cause  systemic  or
local  problems  in  healthy  patients.  However,  infections
systematically  or  locally  emerge  when  the  natural  bal-
ance  between  the  microorganism  and  immune  system  is
disrupted  [4].  Numerous  chemotherapeutic  drugs  in  the
form  of  topical  and  systemic  antifungal  drugs  are  admin-
istered  to  treat  fungal  infections  [5].  The  emergence  of
drug  resistant  forms  of  candidiasis,  especially  in  HIV/AIDS
patients,  is  a  growing  concern  among  clinicians  [6]. Fun-
gal  resistance  can  increase  the  prevalence  of  the  disease.
Moreover,  the  side  effects  of  these  drugs,  such  as  interac-
tions  with  other  drugs  and  hepatotoxicity,  limit  their  use.
Long  periods  of  drug  therapy  and  patient  incompliance  are
probable  in  some  cases  [7,8].  Thus,  research  has  primar-
ily  focused  on  novel  therapeutic  approaches  to  overcome
these  complications  and  to  increase  the  efﬁcacy  of  treat-
ment  [9,10].
Photodynamic  therapy  has  primarily  been  successfully
used  to  treat  malignant  disease  [11,12].  However,  it  has  also
been  indicated  and  deployed  to  treat  bacterial,  fungal  and
viral  infections  in  recent  years.  Antifungal  photodynamic
therapy  is  a  developing  area  of  research  and  has  attracted  a
great  deal  of  attention  in  the  treatment  of  fungal  infections
[13—15].
Photodynamic  therapy  utilizes  the  administration  of  a
light  source  of  speciﬁc  wavelength  and  a  photosensitizer
(PS)  that  accumulates  in  the  target  cell  and  is  activated
by  a  light  source  in  the  presence  of  oxygen.  The  resulting
reaction  induces  cell  death  due  to  the  production  of  toxic
oxygen  species,  such  as  singlet  oxygen  and  or  free  radicals
[16,17].  These  reactions  occur  in  a  limited  space;  thus,  this
type  of  local  therapy  has  additional  beneﬁts  compared  with
systemic  therapy  [16,17].  Among  photosensitizers,  phenoth-
iazinium  derivatives,  including  methylene  blue  and  toluidine
blue,  are  most  commonly  used  to  photodynamically  inac-
tivate  microorganisms  primarily  due  to  their  low  toxicity
and  demonstrated  good  outcomes  in  the  inactivation  of  C.
albicans  [18,19].
The  application  of  a  new  generation  of  photosensitizers
to  increase  the  efﬁcacy  of  anti-fungal  photodynamic  therapy
is  an  important  aspect  of  aPDT.  Thus,  promotion  of  novel  PS
agents  which  allows  to  use  lower  doses  of  PS  and  a  more
selective  reaction  is  important  in  photodynamic  reaction
[20].
When  the  oxygen  content  is  low,  the  efﬁcacy  of  aPDT
may  decrease  due  to  dependency  of  this  process  on  oxy-
gen.  Binding  PS  to  the  target  cell  and  killing  fungal  cells
via  light  activation  increases  the  temperature  of  PS,  but
photothermal  therapy  can  overcome  the  problem  of  oxy-
gen  deﬁciency.  Hence,  photothermal  therapy,  which  is  an
oxygen-dependent  process,  could  have  additional  beneﬁts53
ue  to  its  hyper-thermic  antifungal  mechanism  of  action
21].
The  susceptibility  of  fungal  microorganisms  to  photody-
amic  therapy  has  been  demonstrated  in  vitro  and  in  vivo
22—24]. However,  conclusive  evidence  to  conﬁrm  a  clear
nd  precise  protocol  for  the  photodynamic  destruction
f  fungal  pathogens  is  lacking,  and  further  studies  are
equired.
The  aim  of  this  in  vitro  study  was  to  compare  the  effec-
iveness  of  the  photoelimination  of  C.  albicans  via  two  aPDT
ethods  (new  methylene  blue  and  EmunDo®).
ethods and materials
icroorganism  preparation
 suspension  of  C.  albicans  (PFCC  5027)  with  an  optical
ensity  of  0.5  McFarland  and  106 colony  forming  unit  per
illiliter  (CFU  ml−1)  was  prepared  at  Tarbiat  Modares  Uni-
ersity,  Tehran,  Iran.
hotosensitizer
ew  methylene  blue  N  zinc  chloride  double  salt  (NMBN,
igma—Aldrich,  Germany)  (Fig.  1)  was  purchased,  and  a
0  M  stock  solution  of  NMB  was  prepared  by  dissolving  it
n  phosphate  buffered  saline  (PBS).  This  stock  solution  was
iluted  4-fold  in  the  experiments.  It  was  stored  at  4 ◦C  in
he  dark  until  use.
EmunDo® solution  (A.R.C.  laser  GmbH,  Nurnberg,
ermany)  (Fig.  2) was  prepared  according  to  the  manu-
acturer’s  instructions  at  a  concentrations  of  1  mg/ml  and
tored  in  the  dark.Figure  2  chemical  structure  of  Indocyanin  green.
54  R.  Fekrazad  et  al.
Table  1  Effect  of  treatments  in  each  group  of  study  on  the  viability  of  Candida  albicans  (log-transformed  mean  CFU/ml).
IRLE  IRL  E  CO  RLN  N  RL
Count  (CFU/ml,  E5a)  0.7
(0.48)b,d
1.7
(0.48)a,d,e
1.4
(0.51)d,e
0.03
a,c,e,f,g
0.3
(0.49)b,c,d,g
2.33
(0.19)d
2.50
(0.18)d,e
The letters indicate the presence of statistically signiﬁcant differences for the mentioned group (Games—Howell test: P < 0.05).
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Laser (RL), Infrared Laser (IRL), NMB (N), EmunDo® (E), no light, 
rradiated  for  12.5  min  with  an  output  power  of  10  mW,  emis-
ion  peak  at  630  nm,  spot  area  of  0.5  cm2 and  resultant
nergy  density  of  15  J/cm2.aPDT  with  EmunDo® was  com-
ined  with  a  diode  laser  at  a  wavelength  of  810  nm  (A.R.C.
aser  GmbH,  Nurnberg,  Germany).  According  to  the  man-
facturer’s  recommendations,  the  following  settings  were
sed:  300  mW,  continuous  mode,  30  s  and  resultant  energy
ensity  of  55  J/cm2,  spot  size  of  4.5  mm  to  ensure  to  cover
he  whole  surface  area  of  each  well,  three  times  of  irradia-
ion  in  three  isolated  part  of  well  are  carried  out.
PDT  with  NMB  and  EmunDo®
liquots  of  100  l  of  PS,  fungal  suspension  or  PBS  solu-
ion  were  added  to  the  12  predeﬁned  wells  of  a  96-well
at-bottomed  micro-titer  plate  according  the  speciﬁed
reatment  groups.  The  plates  were  shaken  well  to  ensure
hat  the  suspension  was  well  mixed.  For  the  NMB  group,
 mixture  of  NMB  and  fungal  suspension  was  stored  in  the
ark  at  28  C  for  30  min  and  5  min  for  EmunDo® prior  to  laser
rradiation.  This  process  ensured  sufﬁcient  time  to  allow  for
he  satisfactory  absorption  of  photosensitizer  by  fungal  cell
alls.  The  experimental  and  control  groups  were  classiﬁed
s  the  follows:
.  Experimental  aPDT:  Red  Laser  and  NMB  (RLN)
.  Experimental  aPDT:  Infrared  Laser  and  EmunDo® (IRLE)
.  Positive  control:  Red  Laser  (RL)
.  Positive  control:  Infrared  Laser  (IRL)
.  Positive  control:  NMB  (N)
.  Positive  control:  EmunDo® (E)
.  Negative  control:  no  light,  no  photosensitizer  (CO).
The  ﬁnal  concentrations  of  fungal  suspension,  NMBN  and
munDo® were  0.5  ×  10−5,  2.5  M  and  50  g/ml,  respec-
ively.  All  procedures  were  carried  out  in  a  laminar-ﬂow
ood  in  aseptic  conditions,  and  the  vertical  distance
etween  the  light  device  and  well  surface  were  ﬁxed  in  all
rocesses  with  a  microphone  holder  to  assure  the  accuracy
f  the  desired  laser  energy.  Only  12  wells  were  selected  to
void  the  diffusion  of  laser  light  to  the  adjacent  wells.
After  exposure,  the  suspensions  were  removed  and  seri-
lly  diluted  in  phosphate  buffered  saline  (PBS)  to  give
ilutions  of  10−2—10−4 times  the  original  concentration.
inally,  103 l of  the  diluted  solution  was  added  to  the
abouraud  dextrose  agar  (SDA)  medium  in  petri  dishes.  Each
est  consisted  of  ten  replicates.  After  incubation  in  the  dark
t  37 ◦C  for  48  h,  the  number  of  colony-forming  units  per
illiliter  was  counted  by  a  blind  examiner.
w
r
6
s Laser and NMB (RLN), Infrared Laser and EmunDo (IRLE), Red
otosensitizer (CO).
Continuous  data  are  expressed  as  the  means  (standard
eviation).  The  data  were  analyzed  using  a one-way  analy-
is  of  variance  (ANOVA)  and  Games—Howell  test  for  further
ultiple  comparisons  due  to  a  signiﬁcant  Levene  test.  A  two-
ailed  P-value  less  than  0.05  was  considered  as  statistically
igniﬁcant.
esults
igniﬁcantly  different  colony  counts  were  observed  between
he  groups  involved  (F(6)  =  17.19,  P  <  0.001)  (Table  1).  The
olony  count  of  the  control  group  (CO),  which  was  treated
ith  neither  laser  irradiation  nor  photosensitizer,  was  con-
iderably  higher  those  of  the  other  groups  (P  <  0.05).  aPDT
ith  either  EmunDo® or  new  methylene  blue  (NMB)  con-
iderably  diminished  the  viability  of  inoculated  C.  albicans
P  <  0.001)  by  log  reduction  of  1.9  and  3.37  compared  with
he  control  group  (Fig.  3).  The  difference  between  the
otency  of  the  photosensitizer  alone  E  (EmunDo®)  and  N
NMB)  did  not  reach  statistical  signiﬁcance  (P  =  0.70).  The
ame  trend  was  observed  for  the  light  sources  (IRL:  810  nm
s.  RL:  630  nm);  their  effects  did  not  signiﬁcantly  differ
P  =  0.78).  The  CFU  reduction  was  most  pronounced  in  the
roups  that  were  both  sensitized  and  treated  with  a  laser.
wo  PDT  groups  (IRLE,  810  nm  and  RLN,  630  nm)  equally
educed  the  CFU  counts  (P  =  0.59).
iscussion
n  this  in  vitro  study,  we  demonstrated  the  efﬁcacy  of  the
hoto-inactivation  of  C.  albicans  by  two  new  photosensiti-
ing  agents,  new  methylene  blue  (NMB)  and  EmunDo®.  The
hoto-inactivation  by  both  of  these  photosensitizers  signiﬁ-
antly  reduced  the  viability  of  C.  albicans  by  log  reduction
f  1.9  and  3.37  compared  with  control  group  (P  <  0.001).
Previous  generations  of  phenothiazine  agents,  such  as  MB
nd  TBO,  have  been  conventionally  used  in  aPDT  against
oth  bacterial  and  fungal  microorganisms  [18,19].  Despite
heir  fungicidal  effect,  some  authors  reported  that  these
henothiazine  dyes  are  not  optimal  fungicides  or  their  effec-
ive  killing  doses  for  C.  albicans  are  considerably  high
25,26].  Hence,  examining  new  derivatives  of  phenothiazine
o  increase  the  efﬁcacy  of  aPDT  is  of  crucial  importance.  To
ur  knowledge,  a  limited  number  of  studies  have  investi-
ated  the  efﬁcacy  of  NMB  against  C.  albicans.  Wainwright
t  al.  investigated  the  photo-inactivation  of  C.  albicans
ith  NMB  and  showed  1.74-log  reduction  of  C.  albicans  in
esponse  to  irradiation  with  a  diode  laser  at  a wavelength  of
31  nm  and  energy  density  of  15  J/cm2.  The  results  of  this
tudy  agree  with  this  previous  study  (a  93%  reduction  in  the
In  vitro  photodynamic  inactivation  of  Candida  albicans  55
Figure  3  Effect  of  treatments  in  each  group  of  study  on  the  viability  of  Candida  albicans. Log  reduction  of  colony  forming  unit
per milliliter  (CFU  ml−1)  separated  for  the  applied  photosensitizer  and  corresponding  laser  source  compared  with  control  group.
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light, no  photosensitizer  (CO).
number  of  C.  albicans  colonies  based  on  CFU/ml),  although
the  light  source  in  their  study  was  LED.  Furthermore,  expo-
sure  to  light  or  NMB  alone  did  not  appear  to  signiﬁcantly
affect  C.  albicans,  which  is  similar  to  the  ﬁndings  of  this
study  [26].
We  also  studied  EmunDo®,  which  has  recently  been
popularized  in  the  ﬁeld  of  dentistry.  According  to  the  manu-
facturer’s  statement,  EmunDo® includes  mainly  Indocyanine
green  (ICG),  which  is  a  water-soluble  tri-carbocyanine  dye
with  high  afﬁnity  to  the  near  infrared  region  (  =  810  nm).
ICG  is  approved  by  the  US  food  and  drug  administration  for
medical  diagnostic  studies,  such  as  visualizing  retinal  and
choroidal  vasculatures  [27,28].  The  high  absorption  of  light
in  the  infrared  region  at  805  nm  increases  the  penetration
depth  compared  with  many  other  photosensitizers  [29,30].
ICG  binds  to  the  plasma  protein  and  does  not  undergo  chem-
ical  changes  in  the  body  and  rapidly  excreted  to  the  bile
duct.  It  has  already  been  shown  that  this  dye  has  accept-
able  properties  to  act  as  a  photosensitizer  [29,31,32].  Its
antifungal  killing  mechanism  is  not  precisely  understood,
but  both  photochemical  and  photodynamic  reactions  have
been  implicated  as  a  possible  mechanism  of  action.  While
Gomes  et  al.  observed  that  cells  were  photo-damaged  via
free  radical  formation  after  incubation  with  ICG  [33],  pho-
tothermolysis  is  preponderant  in  killing  sebaceous  glands
in  the  treatment  of  acne  [34].  Nagahara  et  al.  observed
a  signiﬁcant  reduction  of  Porphyromonas  gingivalis  and  a
temperature  increase  of  at  least  4.23 ◦C  in  1  min  after  incu-
bation  with  ICG-loaded  nanospheres  with  an  805  nm  diode
laser  [28].  Fekrazad  et  al.  compared  the  efﬁcacy  of  photo-
thermal  therapy  with  EmunDo® and  PDT  with  Toluidine  blue
O  or  Radachlorin  against  a  standard  suspension  of  Strep-
tococcus  mutans  and  observed  a  signiﬁcant  reduction  of  S.
mutans  after  treatment  with  either  approach  and  no  signiﬁ-
cant  difference  between  the  groups.  They  demonstrated  for
the  ﬁrst  time  that  the  efﬁcacy  of  photo-elimination  therapy
®with  EmunDo in  reducing  the  number  of  S.  mutans  colonies
was  at  least  as  effective  as  those  of  the  other  two  dyes  [21].
To  our  knowledge,  no  study  has  focused  on  utilizing  the
ICG-mediated  photo-inactivation  of  C.  albicans.  Thus,  the
ﬁ
t
i
6aser  (RL),  Infrared  Laser  (IRL),  f:NMB  (N),  c:EmunDo (E),  d:no
ata  obtained  for  aPDT  with  ICG  cannot  be  compared  with
ther  studies.  The  signiﬁcant  reduction  in  the  number  of
.  albicans  after  photo-inactivation  with  EmunDo®,  which
as  similar  to  treatment  with  aPDT  and  NMB,  may  reﬂect
he  potential  efﬁcacy  of  ICG  in  the  photodynamic  or  photo-
hermal  inactivation  of  C.  albicans.  However,  the  precise
echanism  of  action  of  ICG  is  not  clear.  Nevertheless,  a
otential  photothermal  mechanism  could  present  additional
eneﬁts  over  PDT,  especially  in  low  oxygen  areas,  such  as
naerobic  infections  and  deep  periodontal  pockets,  where
xygen  is  limited.  Furthermore,  since  ICG  is  excited  in  higher
avelength  compared  with  NMB  dye,  its  ability  to  pene-
rate  deeper  in  the  tissue  is  higher  than  NMB.  So  presumably
ts  antimicrobial  application  in  deeper  infected  site  is  rein-
orced  [35].  Oxygen  has  clearly  been  described  as  a  crucial
ubstrate  for  photodynamic-derived  antibacterial  action.
otably,  a  wavelength  of  fox  Q810.plus  (810  nm)  is  applica-
le  in  other  procedures  in  dental  practice,  such  as  bleaching,
ow  level  laser  therapy  and  soft  tissue  surgery.
The  application  of  EmunDo® or  NMB  alone  did  not  sig-
iﬁcantly  affect  C.  albicans.  This  ﬁnding  indicated  that  the
ark  toxicity  of  ICG  and  NMB  at  low  concentration  (2.5  M)
s  not  inﬂuential  without  the  application  of  a  laser  source
f  appropriate  wavelength.  Wainwright  et  al.  showed  that
he  minimum  inhibitory  concentration  for  the  dark  toxicity
f  NMB  against  C.  albicans  was  25  M,  and  the  dark  toxicity
gainst  C.  albicans  was  insigniﬁcant  below  this  does.  This
nding  agreed  with  our  study,  which  utilized  2.5  M  NMB
26].
Although  the  dark  toxicities  of  both  lead  dyes  were
nsigniﬁcant  in  our  study,  both  exerted  some  toxic  effects  on
.  albicans  cells.  The  possible  effects  of  both  dyes  on  natural
ost  cells  are  important  to  note,  especially  at  high  concen-
rations.  As  mentioned  above,  Wainwright  et  al.  reported
hat  a  low  concentration  of  NMB  (1  or  2.5  M)  was  only
lightly  toxic  to  mammalian  cells,  but  this  effect  was  ampli-
ed  at  high  concentrations  (10  M)  [26]. Dai  et  al.  assessed
he  efﬁcacy  of  PDT  with  high  concentration  of  NMB;  CFU
nactivation  was  observed  at  20  M  of  NMB,  a  wavelength  of
35  ±  15  nm  and  a  ﬂuency  of  75  J/cm2 for  5  min  and  4.43
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[6  
og.  They  speculated  that  the  improved  efﬁcacy  of  NMB
ompared  with  MB  and  TBO  is  likely  due  to  more  lipophilic
ature  of  NMB,  while  MB  and  TBO  are  hydrophilic  [36].
hese  authors  did  not  examine  high  concentrations;  they
entioned  that  a  high  concentration  of  NMB  exerted  better
ungicidal  effects  than  low  concentrations.  Thus,  the  pre-
ise  minimum  inhibitory  effect  or  optimal  therapeutic  dose
ust  be  determined  while  considering  safety  precautions.
his  information  is  of  crucial  importance  to  treat  resistant
orms  of  candidiasis,  which  may  require  high  concentrations
f  photosensitizing  agents.
The  photoactivation  of  EmunDo® with  a  diode  laser  with
peciﬁc  exposure  parameters  (300  mW,  continuous,  30  s and
nergy  density  of  24  J/cm2)  allowed  for  a  shorter  irradiation
ime  compared  with  the  activation  of  NMB  with  a  red  light
aser,  which  required  an  irradiation  time  of  12.5  min  with
n  output  power  of  10  mW  and  energy  density  of  15  J/cm2.
hus,  an  increased  output  power  and  decreased  exposure
ime  are  desirable  for  therapeutic  targets  and  the  selection
f  laser  system.
While  only  a  limited  number  of  studies  have  demon-
trated  the  efﬁcacy  of  NMB  as  a  novel  photosensitizer,  one
hould  note  that  the  exposure  parameters,  such  as  the
ower,  irradiation  time,  and  energy  density  and  photosen-
itizer  concentration,  differed  among  these  studies,  which
inders  comparisons  between  these  studies.
In  conclusion,  the  photo-elimination  of  C.  albicans  with
ither  new  methylene  blue  or  EmunDo® as  a  photosensi-
izer  can  reduce  the  viability  of  fungal  cells.  Although  the
esult  of  this  study  is  encouraging,  further  investigations  are
arranted  to  determine  the  protocols  to  reliably  and  safely
pply  this  method  in  clinical  practice.
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